Bicycle Therapeutics Plc ADR
(BCYC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -169,031 | -180,664 | -112,717 | -66,819 | -51,010 |
| Depreciation Amortization | 7,174 | 6,546 | 3,689 | 1,409 | 1,277 |
| Income taxes - deferred | -5,226 | 3,306 | -4,976 | -1,668 | N/A |
| Accounts receivable | N/A | 2,482 | -1,641 | 4,543 | -2,149 |
| Accounts payable and accrued liabilities | 3,095 | 8,002 | 2,561 | 1,196 | -663 |
| Other Working Capital | -37,849 | 72,477 | -2,026 | 39,329 | 24,581 |
| Other Operating Activity | 37,113 | 27,223 | 28,999 | 7,216 | 10,175 |
| Operating Cash Flow | $-164,724 | $-60,628 | $-86,111 | $-14,794 | $-17,789 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,235 | -2,929 | -18,987 | -2,030 | -1,200 |
| Investing Cash Flow | $-1,235 | $-2,929 | $-18,987 | $-2,030 | $-1,200 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 15,000 |
| Debt Repayment | -31,863 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 551,655 | 250,027 | 6,692 | 305,725 | 48,416 |
| Other Financing Activity | -42 | 0 | 0 | 15,000 | -573 |
| Financing Cash Flow | $519,750 | $250,027 | $6,692 | $320,725 | $62,843 |
| Exchange Rate Effect | -694 | 1,346 | -1,120 | -1,211 | 19 |
| Beginning Cash Position | 526,970 | 339,154 | 438,680 | 135,990 | 92,117 |
| End Cash Position | 880,067 | 526,970 | 339,154 | 438,680 | 135,990 |
| Net Cash Flow | $353,097 | $187,816 | $-99,526 | $302,690 | $43,873 |
| Free Cash Flow | |||||
| Operating Cash Flow | -164,724 | -60,628 | -86,111 | -14,794 | -17,789 |
| Capital Expenditure | -1,235 | -2,929 | -18,987 | -2,030 | -1,200 |
| Free Cash Flow | -165,959 | -63,557 | -105,098 | -16,824 | -18,989 |